Indefinite Delivery Contract SPE2DU25D5132

The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and U.S. Naval Fleet. The contract covers a broad range of pharmaceutical products and medical supplies, including brand-name and generic drugs, specialty medications, vaccines, syringes, and test kits across multiple therapeutic areas. The contract has a 30-month base period and three 30-month option periods, for a total estimated value of $30.3 billion. The contract is awarded on a regional basis, with at least three different contractors selected for the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.

The original solicitation, which is expected to be issued in March 2024, is for the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts. The procurement is an unrestricted, fully competitive acquisition, with awards made to the responsive and responsible offerors whose proposals are technically acceptable and offer the lowest overall price based on distribution fees. The contract aims to establish Prime Vendor Contracts for the PPV-G program, which provides worldwide pharmaceutical support to various DoD customers, the U.S. Coast Guard, and the U.S. Naval Fleet, including the Hospital Ships USNS Mercy and USNS Comfort.